This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Nov 1;155(9):636-7.

doi: 10.7326/0003-4819-155-9-201111010-00014.

Selecting the optimal stroke prevention therapy in atrial fibrillation

Margaret C Fang

PMID: 22041953
DOI: 10.7326/0003-4819-155-9-201111010-00014

Editorial

Selecting the optimal stroke prevention therapy in atrial fibrillation

Margaret C Fang. Ann Intern Med. 2011.

. 2011 Nov 1;155(9):636-7.

doi: 10.7326/0003-4819-155-9-201111010-00014.

Author

Margaret C Fang

PMID: 22041953
DOI: 10.7326/0003-4819-155-9-201111010-00014

No abstract available

PubMed Disclaimer

Comment on

Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Connolly SJ, Eikelboom JW, Ng J, Hirsh J, Yusuf S, Pogue J, de Caterina R, Hohnloser S, Hart RG; ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators. Connolly SJ, et al. Ann Intern Med. 2011 Nov 1;155(9):579-86. doi: 10.7326/0003-4819-155-9-201111010-00004. Ann Intern Med. 2011. PMID: 22041946 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information